DK1140152T3 - Fremgangsmåde til fremstilling af inaktiverede v/o-emulsion-adjuvans-vacciner - Google Patents

Fremgangsmåde til fremstilling af inaktiverede v/o-emulsion-adjuvans-vacciner

Info

Publication number
DK1140152T3
DK1140152T3 DK99963591T DK99963591T DK1140152T3 DK 1140152 T3 DK1140152 T3 DK 1140152T3 DK 99963591 T DK99963591 T DK 99963591T DK 99963591 T DK99963591 T DK 99963591T DK 1140152 T3 DK1140152 T3 DK 1140152T3
Authority
DK
Denmark
Prior art keywords
inactivated
preparation
emulsion adjuvant
adjuvant vaccines
vaccines
Prior art date
Application number
DK99963591T
Other languages
Danish (da)
English (en)
Inventor
Carla Christina Schrier
Eric Onno Rijke
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1140152T3 publication Critical patent/DK1140152T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK99963591T 1998-12-21 1999-12-15 Fremgangsmåde til fremstilling af inaktiverede v/o-emulsion-adjuvans-vacciner DK1140152T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204348 1998-12-21
PCT/EP1999/010178 WO2000037101A1 (fr) 1998-12-21 1999-12-15 Methode de production de vaccins inactives associes a une emulsion eau dans huile adjuvante

Publications (1)

Publication Number Publication Date
DK1140152T3 true DK1140152T3 (da) 2003-12-01

Family

ID=8234499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99963591T DK1140152T3 (da) 1998-12-21 1999-12-15 Fremgangsmåde til fremstilling af inaktiverede v/o-emulsion-adjuvans-vacciner

Country Status (19)

Country Link
US (1) US6458363B1 (fr)
EP (1) EP1140152B1 (fr)
JP (1) JP2002532559A (fr)
KR (1) KR100626187B1 (fr)
AR (1) AR021948A1 (fr)
AT (1) ATE246512T1 (fr)
AU (1) AU775610B2 (fr)
BR (1) BR9916399A (fr)
CA (1) CA2352563C (fr)
DE (1) DE69910253T2 (fr)
DK (1) DK1140152T3 (fr)
ES (1) ES2205926T3 (fr)
HU (1) HUP0104881A3 (fr)
NZ (1) NZ512302A (fr)
PT (1) PT1140152E (fr)
TR (1) TR200101817T2 (fr)
TW (1) TW577746B (fr)
WO (1) WO2000037101A1 (fr)
ZA (1) ZA200104189B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824279B1 (fr) * 2001-05-04 2004-05-28 Seppic Sa Emulsion e/h concentree
FR2824269B1 (fr) * 2001-09-03 2012-03-02 Seppic Sa Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras
US20050266028A1 (en) * 2004-05-25 2005-12-01 University Of Georgia Research Foundation, Inc. Compositions and methods for modulating an immune response
US8178102B2 (en) 2005-01-19 2012-05-15 Dainippon Sumitomo Pharma Co., Ltd. Emulsified composition for dilution and cancer vaccine composition
DK179025B1 (da) 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine
EP2195021B1 (fr) 2007-08-28 2012-02-29 Université de Liège Herpèsvirus koï (khv) ou herpèsvirus 3 de cyprinidé (cyhv-3) recombiné et vaccin pour prévenir une maladie provoquée par khv/cyhv-3 chez la carpe japonaise ou carpe koï
ES2615390T3 (es) 2008-03-05 2017-06-06 Sanofi Pasteur Proceso para estabilizar una composición de vacuna que contiene adyuvante
MX2010011874A (es) 2008-04-28 2010-11-26 Intervet Int Bv Astrovirus aviar novedoso.
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
HUE033739T2 (en) 2010-10-18 2018-01-29 Intervet Int Bv Turkey herpesvirus vector vaccine against avian influenza in poultry
WO2012130723A1 (fr) 2011-03-25 2012-10-04 Intervet International B.V. Vaccin contre les alphavirus des salmonidés
AR089868A1 (es) 2012-02-03 2014-09-24 Animal Health Inst Vacuna vectorial de eimeria para campylobacter jejuni
CN110438090B (zh) 2013-05-31 2023-12-05 英特维特国际股份有限公司 鳞片脱落疾病(sdd)致病病毒及其衍生物
ES2926813T3 (es) 2015-12-23 2022-10-28 Intervet Int Bv Vacuna contra el calicivirus felino
JP2022537710A (ja) * 2019-06-15 2022-08-29 バイエル・アクチエンゲゼルシヤフト 安定化ジチオカルバメート製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74289A (en) 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
ZA978434B (en) 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.

Also Published As

Publication number Publication date
KR100626187B1 (ko) 2006-09-20
EP1140152A1 (fr) 2001-10-10
AR021948A1 (es) 2002-09-04
DE69910253T2 (de) 2004-06-17
WO2000037101A1 (fr) 2000-06-29
EP1140152B1 (fr) 2003-08-06
ATE246512T1 (de) 2003-08-15
ZA200104189B (en) 2002-08-22
KR20010099871A (ko) 2001-11-09
NZ512302A (en) 2003-08-29
HUP0104881A2 (hu) 2002-04-29
ES2205926T3 (es) 2004-05-01
JP2002532559A (ja) 2002-10-02
TR200101817T2 (tr) 2001-12-21
DE69910253D1 (de) 2003-09-11
AU1983100A (en) 2000-07-12
CA2352563A1 (fr) 2000-06-29
HUP0104881A3 (en) 2003-12-29
CA2352563C (fr) 2010-08-17
US6458363B1 (en) 2002-10-01
TW577746B (en) 2004-03-01
AU775610B2 (en) 2004-08-05
PT1140152E (pt) 2003-11-28
BR9916399A (pt) 2001-09-11

Similar Documents

Publication Publication Date Title
DK1140152T3 (da) Fremgangsmåde til fremstilling af inaktiverede v/o-emulsion-adjuvans-vacciner
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
DK0956281T3 (da) Hidtil ukendte modifikationer af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen, såvel som fremgangsmåder til deres fremstilling
PT1210113E (pt) Composicoes de vacinas de combinacao
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1140886T3 (da) Fremgangsmåde til fremstilling af 5-cyanophtalid
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
DZ2462A1 (fr) Vaccin antigrippal.
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DE60103137D1 (de) Impstoff zur behandlung von atherosclerosis
DK1212084T3 (da) Fremgangsmåde til adskillelse af rotavirus-varianter samt levende, svækket rotavirus-vaccine
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK2465937T3 (da) Fremgangsmåde til fremstilling af 3-O-deaktiveret-4'-monophosphoryllipid A (3D-MLA)
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1142990T3 (da) Fremgangsmåde til fremstilling af transglutaminase
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
NO20022333L (no) Ny anvendelse av antistoffer som vaksiner
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
EE200100453A (et) Betahistiini reguleeritult vabastav preparaat
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0951561T3 (da) Enzymatiske fremgangsmåder til fremstilling af (S)-cyanhydriner
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater